111, Inc. Sponsored ADR

YI Healthcare Medical Distribution

111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.

3.09 0.00 0.00%
Market cap
$16.0M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
3.31
Beneish M
−3.28
Dividend safety
n/a
Older periods Jun '25 Sep '25 Dec '25 Mar '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.03 0.02 0.01 0.03
P/FCF ratio
0.00 0.00 2.75 0.00
P/Operating CF
(7.40) 7.35 4.95 (4.31)
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.01 (0.01) (0.02) 0.02
EV/EBITDA
0.00 11.29 112.75 0.00
EV/Operating CF
0.91 (3.55) (2.25) (3.16)
EV/FCF
(5.29) 1.06 (4.73) (1.80)
Quick Ratio
0.37 0.38 0.45 0.34
Current Ratio
1.13 1.07 1.09 1.08
Net Debt/EBITDA
(3,684.23) 169.59 1,147.50 6.96
Debt/Assets
6.86% 6.85% 8.53% 13.32%
Debt/Equity
(0.25) (0.24) (0.26) (0.34)
Asset Turnover
5.34 4.75 5.16 5.16
Operating CF/Net income
3.07 (2.96) (1.79) 2.48
Capex/Depreciation
— — (0.37) —
Interest Coverage
0.01 (0.32) (0.03) (2.54)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.61% 2.58% 2.84% 2.99%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(1.81) (2.83) (5.12) (2.10)
Graham Number
14.50 14.65 16.33 19.85
Earnings Yield
(11.76%) (18.46%) (39.06%) (21.47%)
Free Cash Flow Yield
(4.29%) (35.09%) 36.37% (36.12%)
Revenue per Share
51.56 48.39 50.58 38.93
Operating CF per Share
(0.96) 0.62 0.52 (1.51)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.96) 0.62 0.52 (1.51)
Cash per Share
8.25 8.99 10.05 6.54
Shareholders Equity per Share
(11.12) (11.36) (11.86) (12.51)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(11.12) (11.36) (11.86) (12.51)
Free Cash Flow
(8.37) 5.39 4.50 (13.30)
Working Capital
36.89 22.72 24.48 20.81
Capital Expenditures
— — (0.62) —
Net Current Asset Value
(111.88) (112.14) (113.95) (120.59)
EV/EBIT
0.00 11.29 112.72 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
46.82 50.07 46.87 32.07
Average Payables
218.42 245.12 209.61 203.65
Average Inventory
183.28 197.24 166.43 166.20
Average Assets
364.76 390.21 348.28 319.93
Average Common Equity
(91.12) (94.80) (96.67) (101.44)

Fold the line items

Columns are period end dates